Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01890616 · ClinicalTrials.gov registry record
Constipation and Gut Transit in DMD Patients
A clinical trial, sponsored by Children's Hospital Medical Center, Cincinnati.
- Completed
- Registry status
- 8
- Enrollment target
NCT01890616: Completed study, sponsored by Children's Hospital Medical Center, Cincinnati.
NCT01890616 is a clinical trial that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 8 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01890616 has completed, sponsored by Children's Hospital Medical Center, Cincinnati.
- COMPLETED
- Registry status
- 8 participants
- Enrollment target
Study Summary
In this research study the investigators want to screen Duchenne Muscular Dystrophy (DMD) patients for signs and symptoms of constipation in patients over 18. The investigators hypothesized: * DMD patients have a high prevalence of constipation than in the general population. * Prevalence of constipation will increase with age and with worsening functional status.
Primary Outcome
Gi transit times will be computed by an investigator.
Interventions
- DEVICE SmartPill ingestion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2013-05-01 |
| Est. Completion | 2015-07-01 |
What the finished NCT01890616 record still lists
NCT01890616 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 8 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which SmartPill ingestion is the first listed.
NCT01890616 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01890616 about?
NCT01890616 is a clinical study titled "Constipation and Gut Transit in DMD Patients". In this research study the investigators want to screen Duchenne Muscular Dystrophy (DMD) patients for signs and symptoms of constipation in patients over 18. The investigators hypothesized: * DMD patients have a high prevalence of constipation than in the general population. * Prevalence of const...
What is the current status of trial NCT01890616?
This trial is currently completed. The enrollment target is 8 participants. The study started on 2013-05-01. Estimated completion is 2015-07-01.
What interventions are being tested in trial NCT01890616?
The interventions under investigation include: SmartPill ingestion (DEVICE).
Who is sponsoring clinical trial NCT01890616?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI